Financhill
Back

Marinus Pharmaceuticals Stock Predictions

Marinus Pharmaceuticals Stock Forecast

  • Is Marinus Pharmaceuticals Stock Undervalued?
    The current Marinus Pharmaceuticals [MRNS] share price is $1.61. The Score for MRNS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Marinus Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Marinus Pharmaceuticals Stock Rating

Data Unavailable

Marinus Pharmaceuticals Stock Price History

Is MRNS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRNS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
marinuspharma.com

52-Week Data

52-Week High:
11.26
52-Week Low:
1.05

Prediction Charts

Market Cap:
88.41M
Price in USD:
1.61
Volume:
420.63K
Beta:
1.67

Technical Analysis

SMA50:
1.37
SMA100:
1.38
SMA200:
5.01
52-Wk Change:
-77.15%

Stock Predictions

  • Is Marinus Pharmaceuticals stock public?
    Yes, Marinus Pharmaceuticals is a publicly traded company.
  • What is the Marinus Pharmaceuticals stock quote today?
    The Marinus Pharmaceuticals stock price is 1.61 USD today.
  • How to buy Marinus Pharmaceuticals stock online?
    You can buy Marinus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 1.43 1.42 1.43 1.35
Sep-3 1.40 1.44 1.46 1.37
Sep-4 1.43 1.42 1.46 1.39
Sep-5 1.41 1.39 1.42 1.39
Sep-6 1.39 1.40 1.43 1.34
Sep-9 1.42 1.40 1.45 1.38
Sep-10 1.38 1.40 1.42 1.37
Sep-11 1.39 1.40 1.43 1.38
Sep-12 1.40 1.40 1.41 1.38
Sep-13 1.40 1.50 1.51 1.40
Sep-16 1.50 1.55 1.58 1.47
Sep-17 1.56 1.55 1.61 1.54
Sep-18 1.56 1.53 1.61 1.50
Sep-19 1.56 1.61 1.62 1.52

Marinus Pharmaceuticals Earnings

Data Unavailable

Marinus Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.21 per share, an increase this year of $0.63 per share, and an increase next year of $0.90 per share.

* Marinus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.